Paramount Skydance CEO David Ellison is pushing back against California AG Rob Bonta's lawsuit blocking the $81 billion merger with Warner Bros. Discovery, warning that blocking the deal could lead to job losses in Hollywood and the eventual takeover of studios by tech giants like Amazon and Apple. Ellison argues that traditional studios need to merge to compete with tech companies and that the merger is crucial for Warner Bros. Discovery's financial health, which currently carries $30 billion in debt. The merger has been approved globally except by a few state attorneys general, with no settlement talks yet scheduled. Ellison also threatens to move Paramount's operations out of California if no agreement is reached by October 1, while facing a costly daily fee if the deal doesn't close soon.
In Q3 2026, websites on Cloudflare's network blocked 13.47% of AI crawler requests, more than double the 5.98% blocked a year earlier. This rise in access denial affects how brands appear in AI-generated answers from platforms like ChatGPT, Gemini, a...
JPMorgan Asset Management (Canada) announced the final cash distributions for September 2026 for three of its ETFs traded on the Toronto Stock Exchange. Unitholders of record on October 19, 2026, will receive payments on October 23, 2026. The ETFs an...
Stillwater Critical Minerals Corp. has upgraded to the OTCQX Best Market from the OTCQB Venture Market, beginning trading under the symbol "PGEZF." This move enhances the company's visibility, liquidity, and accessibility to U.S. investors as it adva...
WasabiCard, a stablecoin-based global payment provider, engaged in key partnership discussions at TOKEN2049 Singapore 2026, focusing on white-label card issuing, global payouts, and embedded payments. The company highlighted growing demand in APAC fo...
The global next generation antibody therapeutics market is projected to increase from $5.45 billion in 2026 to $5.76 billion by 2035, growing at a CAGR of 1%. Growth is fueled by advances in biotechnology, rising demand for targeted therapies, and in...
